What an amazing #HOPAAC22. Had a great time seeing old friends and meeting new ones, learning a TON, and debating Jessie Signorelli about the optimal induction therapy for AML.

So proud of our PGY2 residents in Oncology UChicago Medicine Pharmacy Residency Programs. They have worked so hard and are going to do some awesome things in their careers! #HOPAAC22

Congratulations to Dr. Adam DuVall MD, MPH, our fellow Dr. Sheade, and Dr. Stock on their new manuscript in JCO Oncology Practice. #AYA #leusm ascopubs.org/doi/full/10.12…

nobody: absolutely fucking nobody: 🇺🇸: let’s force women to give birth despite our abysmal maternal mortality rate (for which we have done no major health reform) and then do nothing to keep the kids alive either (because 2A ✌🏻)

Excited to present our newest paper in JAMA Oncology highlighting the discrepancy of QTc values and its effect in mgmt of onc pts. This was a true tour de force led by Daniel Richardson, @pcparish, Benyam Muluneh, PharmD, BCOP, FHOPA UNC Lineberger /1 jamanetwork.com/journals/jamao…

Our review on newly-dx AML is in JCO Oncology Practice! Had the pleasure of writing it w/ star fellow (University of Chicago Hem/Onc Fellows) Dr Jen Cooperrider, star resident (MedChiefs) Dr Navika Shukla & my wonderful colleague Mariam Nawas! #leusm ascopubs.org/doi/abs/10.120…

We meet the occasional AML pt with a FLT3 mutation outside the classic ITD/TKD sites. A common one is FLT3 N676K. Check out our new UChicago Leukemia Program analysis of this atypical variant's responsiveness to FLT3i Michael Drazer UChicagoCancerCenter University of Chicago Hem/Onc Fellows haematologica.org/article/view/h…

aspiring pharmacists— I will read and provide feedback on your cover letters and CVs for free. the journey is hard and expensive enough as is, please don’t buy in to things like this. especially when they’re dragging you.

Anyone know anyone with Fall Out Boy who could help a badass chicago-based AYA cancer survivor's dreams come true this June?? 🤩🤠

.UChicagoCancerCenter is joining an elite national network to lead the charge in evidence-based cancer treatments and improved patient outcomes. ms.spr.ly/6019g1XPf

So proud of my good friend Erin McCreary! She is a rockstar pharmacist, tremendous leader and my favorite resource for all my ID questions.

Full abstracts from #ASCO24 are out! Check out our abstract led by Leah Goldberg on peg-asparaginase dosing in ALL and therapeutic levels achieved with lower doses #leusm meetings.asco.org/abstracts-pres…